Literature DB >> 12609127

The postictal state: a neglected entity in the management of epilepsy.

R S Fisher1, S C Schachter2.   

Abstract

Some of the disability deriving from epilepsy derives from the postictal state (PS). The PS may be complicated by impaired cognition, headache, injuries, or secondary medical conditions. Postictal depression is common, postictal psychosis relatively rare, but both add to the morbidity of seizures. The mechanisms of the PS are poorly understood. Alteration of cerebral blood flow both results from and contributes to the PS. Many neurotransmitters or neuromodulators are involved in the physiology of the PS. Response to glutamate may partially desensitize after a seizure. Endogenous opiates and adenosine serve as natural antiepileptic medications in some circumstances. Nitric oxide has numerous effects on brain excitability, and may be particularly important in regulating postictal cerebral blood flow. Just as the pathophysiology of seizures is complicated, so is that of the PS multifactorial. As a practical issue, it would be very useful to have medications that reduce the morbidity of the PS. Copyright Â
© 2000 Academic Press. All rights reserved.

Entities:  

Year:  2000        PMID: 12609127     DOI: 10.1006/ebeh.2000.0023

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  26 in total

Review 1.  The postictal state: effects of age and underlying brain dysfunction.

Authors:  William H Theodore
Journal:  Epilepsy Behav       Date:  2010-08-17       Impact factor: 2.937

Review 2.  Abnormalities of serotonergic neurotransmission in animal models of SUDEP.

Authors:  Hua-Jun Feng; Carl L Faingold
Journal:  Epilepsy Behav       Date:  2015-08-10       Impact factor: 2.937

3.  Introduction to focus issue: rhythms and dynamic transitions in neurological disease: modeling, computation, and experiment.

Authors:  Tasso J Kaper; Mark A Kramer; Horacio G Rotstein
Journal:  Chaos       Date:  2013-12       Impact factor: 3.642

4.  Sleep-dependent memory consolidation in the epilepsy monitoring unit: A pilot study.

Authors:  Rani A Sarkis; Javad Alam; Milena K Pavlova; Barbara A Dworetzky; Page B Pennell; Robert Stickgold; Ellen J Bubrick
Journal:  Clin Neurophysiol       Date:  2016-05-31       Impact factor: 3.708

5.  Epileptic seizures increase circulating endothelial cells in peripheral blood as early indicators of cerebral vascular damage.

Authors:  Helena Parfenova; Charles W Leffler; Dilyara Tcheranova; Shyamali Basuroy; Aliz Zimmermann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

6.  Thalamic stimulation to improve level of consciousness after seizures: evaluation of electrophysiology and behavior.

Authors:  Abhijeet Gummadavelli; Joshua E Motelow; Nicholas Smith; Qiong Zhan; Nicholas D Schiff; Hal Blumenfeld
Journal:  Epilepsia       Date:  2014-12-02       Impact factor: 5.864

7.  Enteral supplements of a carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by neonatal seizures.

Authors:  Jianxiong Liu; Alexander L Fedinec; Charles W Leffler; Helena Parfenova
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

8.  Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.

Authors:  Ryan J Schutte; Soleil S Schutte; Jacqueline Algara; Eden V Barragan; Jeff Gilligan; Cynthia Staber; Yiannis A Savva; Martin A Smith; Robert Reenan; Diane K O'Dowd
Journal:  J Neurophysiol       Date:  2014-05-07       Impact factor: 2.714

9.  Local cortical hypoperfusion imaged with CT perfusion during postictal Todd's paresis.

Authors:  Marlon S Mathews; Wade S Smith; Max Wintermark; William P Dillon; Devin K Binder
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

10.  Spectral and spatial shifts of post-ictal slow waves in temporal lobe seizures.

Authors:  Lin Yang; Gregory A Worrell; Cindy Nelson; Benjamin Brinkmann; Bin He
Journal:  Brain       Date:  2012-08-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.